Helius Medical Technologies Inc. held a special meeting of stockholders on May 23, 2025. The stockholders approved several proposals, including a reverse stock split, an increase in the number of authorized shares of common stock to up to 800,000,000 shares, and the issuance of up to 148,621,326 shares of common stock in a potential financing. Additionally, an amendment to the 2022 Equity Incentive Plan was approved, as well as the authorization to adjourn the meeting to solicit additional proxies if needed.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Helius Medical Technologies Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001558370-25-008132), on May 23, 2025, and is solely responsible for the information contained therein.